Biogen Inc. buy Royal Bank of Canada
Start price
30.07.26
/
50%
€179.42
Target price
30.07.27
€209.52
Performance (%)
2.22%
Price
09:53
€183.40
Summary
This prediction is currently active. With a performance of 2.22%, the BUY prediction by Royal_Bank_of_Canada for Biogen Inc. is trending in the right direction. This prediction currently runs until 30.07.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biogen Inc. | 2.033% |
| iShares Core DAX® | 0.881% |
| iShares Nasdaq 100 | 2.390% |
| iShares Nikkei 225® | 4.269% |
| iShares S&P 500 | 1.171% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) was given a new $240.00 price target by Royal Bank Of Canada. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat